Indication

Enterobacter pneumonia

Enterobacter pneumonia is a bacterial lower respiratory tract infection caused by opportunistic, Gram-negative bacilli of the genus *Enterobacter*, most frequently members of the *Enterobacter cloacae* complex. Read more about Enterobacter pneumonia

210 drugs 92 manufacturers

Advertisement

Drugs that treat it

Common Enterobacter pneumonia therapies.

Showing 28–36 of 210 drugs

Filter & compare in the drug finder →Opens the drug finder with Enterobacter pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Enterobacter pneumonia.

Enterobacter pneumonia is a bacterial lower respiratory tract infection caused by opportunistic, Gram-negative bacilli of the genus *Enterobacter*, most frequently members of the *Enterobacter cloacae* complex.

It primarily manifests as a nosocomial infection—such as hospital-acquired pneumonia or ventilator-associated pneumonia—affecting hospitalized, critically ill, or immunocompromised individuals, as well as elderly patients with structural lung disease.

Pathophysiologically, the condition involves the microaspiration of colonizing oropharyngeal flora or contaminated respiratory equipment into the lower respiratory tract, triggering acute alveolar inflammation and tissue consolidation.

Clinical presentation includes fever, dyspnea, hypoxemia, purulent sputum production, and new pulmonary infiltrates on chest imaging, often complicated by inducible AmpC beta-lactamase production that drives resistance to multiple beta-lactam antimicrobials.

Personalize your experience

Follow Enterobacter pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it